Alemtuzumab in Lung Transplantation: An Open-Label, Randomized, Prospective Single Center Study

Effect of Cytomegalovirus Immunoglobulin on the Incidence of Lymphoproliferative Disease After Lung Transplantation

(2013) Peter Jaksch et al.   TRANSPLANTATION

The Registry of the International Society for Heart and Lung Transplantation: 29th Adult Lung and Heart-Lung Transplant Report—2012

(2012) Jason D. Christie et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Five-year outcomes with alemtuzumab induction after lung transplantation

(2011) Susan Shyu et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Investigation of Lymphocyte Depletion and Repopulation Using Alemtuzumab (Campath-1H) in Cynomolgus Monkeys

(2010) D. J. van der Windt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation

(2008) Gorav Ailawadi et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Campath Induction for Kidney Transplantation: Report of 297 Cases

(2008) Jorge Ortiz et al.   TRANSPLANTATION

Campath-1H (Alemtuzumab) as an Induction Agent for the Prevention of Graft Rejection and Preservation of Renal Function in Kidney Transplant Patients: Philippine 3-Year Follow-up

(2008) A.S. Muñoz et al.   TRANSPLANTATION PROCEEDINGS